Company Profile
Updated: 28-OCT-09PharmaMar SAU
Non-Quoted Public Company
Avda de los Reyes 1, Pol Ind La Mina Norte, Colmenar Viejo, E-28770, Spain
()34 91 846 60 00, 34 91 846 60 01 fax, http://www.pharmamar.es
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: PharmaMar is the world leader biopharmaceutical company of the Zeltia Group, committed to advancing the treatment of cancer through the discovery and development of new marine-derived medicines
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL.
PR Newswire; 9/10/2009; 663 words; ...machinery. Under a licensing agreement with PharmaMar SAU of Spain, Centocor Ortho Biotech Products...where the product is marketed as YONDELIS by PharmaMar SAU and Japan, where PharmaMar SAU and Taiho Pharmaceutical CO., LTD. have a...
Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer.
PR Newswire; 7/15/2009; 686 words; ...repair machinery. Under a licensing agreement with PharmaMar SAU of Spain, Centocor Ortho Biotech Products, L.P...where the product is marketed as YONDELIS(R) by PharmaMar SAU. About Centocor Ortho Biotech Products, L.P. Centocor...
Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting.
PR Newswire; 5/28/2009; 3657 words; ...Johnson PRD, USA, Raritan, NJ; PharmaMar SAU, Colmenar Viejo, Madrid, Spain...Development, Raritan, NJ; PharmaMar SAU, Madrid, Spain; University...Cancer Center UC, Orange, CA; PharmaMar SAU, Madrid, Spain; Johnson &...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning